Accuray, Inc. is a radiation therapy company, which engages in manufacturing medical equipment. The company is headquartered in Madison, Wisconsin and currently employs 990 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Mr. Stephen La Neve est le President de Accuray Inc, il a rejoint l'entreprise depuis 2025.
Quelle est la performance du prix de l'action ARAY ?
Le prix actuel de ARAY est de $0.3861, il a diminué de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Accuray Inc ?
Accuray Inc appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de Accuray Inc ?
La capitalisation boursière actuelle de Accuray Inc est de $45.8M
Est-ce que Accuray Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 4 analystes ont établi des notations d'analystes pour Accuray Inc, y compris 4 achat fort, 3 achat, 1 maintien, 0 vente et 4 vente forte